GMP β-Amyloid (1-42), Human - 5 mg NET

IVD (in vitro Diagnostics); QC Controls & Standards; Pre-Clinical animal studies (Not to be used as an API in it's current form)

beta-amyloid; beta-amyloid (1-42)

- 20°C ± 5°C

This highly pure, well-characterized GMP beta-Amyloid (1-42) peptide has been produced under conditions compliant with 21 CFR part 820 and ISO 13485.Features & BenefitsAdded Assurance for your high profile projectsCompliant with 21 CFR part 820 and ISO 13485Manufactured in controlled areas under SOP's, BR's, with qualified equipment and staffLot to lot reproducibility, consistency, and traceabilityComprehensive QC Testing and characterizationApplications*Ideal for:In Vitro DiagnosticsQC Controls & StandardsPre-Clinical animal studies*Not to be used as an API in it's current formTestingAdditional test results available on Certificate of Analysis Attribute Result: Peptide Purity>=97%, Endotoxin <0.05 EU/mg, Bioburden <1 CFU/mg, SolubilityAqueous media (see CoA), Monomer content>=97%

Neuroscience / Lyophilized

5400535174484

<= 1 EU/mg

12352202